These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1934674)
1. Comment on "Irreversible ocular toxicity from single challenge dose of desferrioxamine" by C. Bene et al. Yaqoob M; Prabhu P; Ahmad R Clin Nephrol; 1991 Sep; 36(3):155. PubMed ID: 1934674 [No Abstract] [Full Text] [Related]
2. Irreversible ocular toxicity from single "challenge" dose of deferoxamine. Bene C; Manzler A; Bene D; Kranias G Clin Nephrol; 1989 Jan; 31(1):45-8. PubMed ID: 2783668 [TBL] [Abstract][Full Text] [Related]
3. Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease. Marumo F; Umetani N; Sato N; Takahashi Y J UOEH; 1987 Mar; 9 Suppl():140-52. PubMed ID: 3602745 [No Abstract] [Full Text] [Related]
4. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient]. Bournerias F; Monnier N; Dufier JL; Réveillaud RJ Nephrologie; 1987; 8(1):27-9. PubMed ID: 3587485 [TBL] [Abstract][Full Text] [Related]
5. [Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis]. Martín C; Lens XM; Prieto A; Alonso R; Correa B; Arcocha V; Soto A An Otorrinolaringol Ibero Am; 1994; 21(2):193-8. PubMed ID: 8209972 [TBL] [Abstract][Full Text] [Related]
6. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis]. Simon P Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038 [No Abstract] [Full Text] [Related]
7. Effect of desferrioxamine on aluminum kinetics during hemodialysis. Stummvoll HK; Graf H; Meisinger V Miner Electrolyte Metab; 1984; 10(4):263-6. PubMed ID: 6749073 [TBL] [Abstract][Full Text] [Related]
8. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test. Roodhooft AM; van de Vyver FL; D'Haese PC; van Acker KJ; Visser WJ; de Broe ME Clin Nephrol; 1987 Sep; 28(3):125-9. PubMed ID: 3665205 [TBL] [Abstract][Full Text] [Related]
9. Desferrioxamine in the treatment of aluminum overload. Ackrill P; Day JP Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106 [TBL] [Abstract][Full Text] [Related]
10. [Tissue overload of aluminum in hemodialysis patients. The desferrioxamine test]. Simon P; Ang KS; Tanquerel T; Allain P; Mauras Y Nouv Presse Med; 1982 Jan; 11(3):209. PubMed ID: 7058145 [No Abstract] [Full Text] [Related]